Red blood cell membrane functionalized biomimetic nanoparticles for systemic lupus erythematosus treatment
Cyclosporin A (CsA) is a powerful immunosuppressant often used to treat Systemic lupus erythematosus (SLE). However, current CsA formulations have poor bioavailability and high pharmacokinetic variability, which have greatly affected its further application in clinical. Nanomaterials can enhance the...
Main Authors: | Xubin Hao, Hui Zhang, Rui Liu, Junyi Che, Dagan Zhang, Jun Liang, Lingyun Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Materials Today Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259004982200090X |
Similar Items
-
Biomimetic liposomes hybrid with erythrocyte membrane modulate dendritic cells to ameliorate systemic lupus erythematosus
by: Xubin Hao, et al.
Published: (2023-06-01) -
Aplastic Anemia Complicating Systemic Lupus Erythematosus
by: Anu Maheshwari, et al.
Published: (2021-01-01) -
Sustained Remission in a Case of Lupus Nephritis with Cyclosporin Therapy
by: Rabbani Malik, et al.
Published: (2001-01-01) -
Therapeutic Drug Monitoring in Patients with Systemic Lupus Erythematosus: Utility and Gaps
by: Kar Mun Chong, et al.
Published: (2024-01-01) -
A Case of Systemic Lupus Erythematosus Presenting as Pure Red Cell Aplasia
by: Maria Saeed, et al.
Published: (2021-04-01)